Non-Hodgkin's Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Condition: Lymphoma, Non-Hodgkin Intervention: Drug: DZD8586 Sponsor: Dizal Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
Condition: Refractory or Relapsed B-cell Non-Hodgkin Lymphoma Intervention: Drug: dualCAR-NK19/70 cell Sponsor: Aibin Liang，MD，Ph.D. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Condition: Lymphoma, Non-Hodgkin Intervention: Drug: DZD8586 Sponsor: Dizal Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
Condition: Refractory or Relapsed B-cell Non-Hodgkin Lymphoma Intervention: Drug: dualCAR-NK19/70 cell Sponsor: Aibin Liang，MD，Ph.D. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Condition: Lymphoma, Non-Hodgkin Intervention: Drug: DZD8586 Sponsor: Dizal Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
Condition: Refractory or Relapsed B-cell Non-Hodgkin Lymphoma Intervention: Drug: dualCAR-NK19/70 cell Sponsor: Aibin Liang，MD，Ph.D. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Condition: Lymphoma, Non-Hodgkin Intervention: Drug: DZD8586 Sponsor: Dizal Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
